Physician profile
Gary L Postelwait
NPI 1972523934
$1,379.82
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,260 · 2020: $120.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $261.67 | 2019-2020 | |
| Pfizer INC. | $240.56 | 2019-2020 | |
| Amgen INC. | $139.80 | 2019 | |
| Janssen Pharmaceuticals, INC | $72.35 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $66.93 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $65.33 | 2019-2020 | |
| Glaxosmithkline, LLC. | $60.92 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $56.66 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $53.35 | 2019 | |
| Lilly USA, LLC | $53.12 | 2019 | |
| Astellas Pharma US INC | $51.96 | 2019 | |
| Antares Pharma, INC. | $35.85 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.16 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $26.55 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $25.78 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $25.44 | 2019 | |
| Mylan Specialty L.P. | $21.56 | 2020 | |
| Amarin Pharma, INC. | $18.62 | 2019 | |
| Shionogi INC | $15.02 | 2019 | |
| Shire North American Group INC | $14.15 | 2019 | |
| Therapeuticsmd, INC. | $13.93 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.32 | 2019 | |
| Merck Sharp & Dohme LLC | $12.79 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Postelwait listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.